Clinical Trials Directory

Trials / Conditions / Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

10 registered clinical trials studyying Cutaneous T-Cell Lymphoma/Mycosis Fungoides — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingLong-term Assessment of Chlormethine Gel in Mycosis Fungoides
NCT07046663
Fondazione Italiana Linfomi - ETS—
RecruitingSystemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868
Fondazione Italiana Linfomi - ETS—
CompletedReal World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
NCT06113081
Fondazione Italiana Linfomi - ETS—
RecruitingA Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
NCT06436677
Peking University First Hospital—
CompletedHyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
NCT06149247
SoligenixPhase 2
CompletedPK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
NCT05380635
SoligenixPhase 2
TerminatedPRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the S
NCT03837457
miRagen Therapeutics, Inc.Phase 2
TerminatedSOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides
NCT03713320
miRagen Therapeutics, Inc.Phase 2
CompletedStudy of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)
NCT04702503
Moleculin Biotech, Inc.Phase 1
TerminatedPUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides
NCT00630903
Madrilenian Group of Cutaneous LymphomasPhase 4